Fla. Stat. 465.0252
Substitution of interchangeable biosimilar products


(1)

As used in this section, the terms “biological product,” “biosimilar,” and “interchangeable” have the same meanings as defined in s. 351 of the federal Public Health Service Act, 42 U.S.C. s. 262.

(2)

A pharmacist may only dispense a substitute biological product for the prescribed biological product if:The United States Food and Drug Administration has determined that the substitute biological product is biosimilar to and interchangeable for the prescribed biological product.The prescribing health care provider does not express a preference against substitution in writing, verbally, or electronically.The pharmacist notifies the person presenting the prescription of the substitution in the same manner as provided in s. 465.025(3)(a).The pharmacist retains a written or electronic record of the substitution for at least 2 years.

(a)

The United States Food and Drug Administration has determined that the substitute biological product is biosimilar to and interchangeable for the prescribed biological product.

(b)

The prescribing health care provider does not express a preference against substitution in writing, verbally, or electronically.

(c)

The pharmacist notifies the person presenting the prescription of the substitution in the same manner as provided in s. 465.025(3)(a).

(d)

The pharmacist retains a written or electronic record of the substitution for at least 2 years.

(3)

A pharmacist who practices in a Class II, Modified Class II, or Class III institutional pharmacy shall comply with the notification provisions of paragraph (2)(c) by entering the substitution in the institution’s written medical record system or electronic medical record system.

(4)

The board shall maintain on its public website a current list of biological products that the United States Food and Drug Administration has determined are biosimilar and interchangeable as provided in paragraph (2)(a).

Source: Section 465.0252 — Substitution of interchangeable biosimilar products, https://www.­flsenate.­gov/Laws/Statutes/2024/0465.­0252 (accessed Aug. 7, 2025).

465.001
Short Title
465.002
Legislative findings
465.003
Definitions
465.004
Board of Pharmacy
465.005
Authority to make rules
465.006
Disposition of fees
465.007
Licensure by examination
465.008
Renewal of license
465.009
Continuing professional pharmaceutical education
465.012
Reactivation of license
465.013
Registration of pharmacy interns
465.014
Pharmacy technician
465.015
Violations and penalties
465.016
Disciplinary actions
465.017
Authority to inspect
465.018
Community pharmacies
465.019
Institutional pharmacies
465.022
Pharmacies
465.023
Pharmacy permittee
465.024
Promoting sale of certain drugs prohibited
465.025
Substitution of drugs
465.026
Filling of certain prescriptions
465.027
Exceptions
465.035
Dispensing of medicinal drugs pursuant to facsimile of prescription
465.0075
Licensure by endorsement
465.0125
Consultant pharmacist license
465.0126
Nuclear pharmacist license
465.0155
Standards of practice
465.0156
Registration of nonresident pharmacies
465.0157
International export pharmacy permit
465.0158
Nonresident sterile compounding permit
465.0161
Distribution of medicinal drugs without a permit
465.0181
Community pharmacy permit required to dispense Schedule II or Schedule III controlled substances
465.185
Rebates prohibited
465.186
Pharmacist’s order for medicinal drugs
465.187
Sale of medicinal drugs
465.188
Medicaid audits of pharmacies
465.189
Administration of vaccines and epinephrine autoinjection
465.0193
Nuclear pharmacy permits
465.0196
Special pharmacy permits
465.0197
Internet pharmacy permits
465.0235
Automated pharmacy systems used by long-term care facilities, hospices, or state correctional institutions, or for outpatient dispensing
465.0244
Information disclosure
465.0251
Generic drugs
465.0252
Substitution of interchangeable biosimilar products
465.0255
Expiration date of medicinal drugs
465.0265
Centralized prescription filling
465.0266
Common database
465.0275
Emergency prescription refill
465.0276
Dispensing practitioner
465.1861
Ordering and dispensing HIV infection prevention drugs
465.1865
Collaborative pharmacy practice for chronic health conditions
465.1893
Administration of antipsychotic medication by injection
465.1895
Testing or screening for and treatment of minor, nonchronic health conditions
465.1901
Practice of orthotics and pedorthics
465.1902
Prescription Drug Donation Repository Program

Current through Fall 2025

§ 465.0252. Substitution of interchangeable biosimilar products's source at flsenate​.gov